
| Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung #MMPMID32534505Dastan F; Abedini A; Shahabi S; Kiani A; Saffaei A; Zare AIran J Allergy Asthma Immunol 2020[May]; 19 (S1): 10-12 PMID32534505show ga
?|*Drug Repositioning[MESH]|Angiotensin-Converting Enzyme 2[MESH]|Betacoronavirus/*drug effects[MESH]|COVID-19[MESH]|Coronavirus Infections/*drug therapy/metabolism[MESH]|Cytokines/drug effects[MESH]|Dipeptidyl Peptidase 4/drug effects/metabolism[MESH]|Dipeptidyl-Peptidase IV Inhibitors/*pharmacology[MESH]|Humans[MESH]|Inflammation/drug therapy/virology[MESH]|Lung/drug effects/metabolism[MESH]|Pandemics[MESH]|Peptidyl-Dipeptidase A/drug effects/metabolism[MESH]|Pneumonia, Viral/*drug therapy/metabolism[MESH]|SARS-CoV-2[MESH]
  
DeepDyve Pubget Overpricing | 
|